These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7665229)

  • 1. Progression toward metastatic phenotype with loss of growth-inhibiting tumor-cell/cell interactions in vivo.
    Takeda Y; Sayama K; Saegusa Y; Matsuzawa A
    Int J Cancer; 1995 Sep; 62(5):579-84. PubMed ID: 7665229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors.
    Tsubura A; Inui T; Morii S; Dairkee SH; Oikawa T; Matsuzawa A
    Breast Cancer Res Treat; 1991; 17(3):239-43. PubMed ID: 1710155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction.
    Imagawa W; Bandyopadhyay GK; Garcia M; Matsuzawa A; Nandi S
    Cancer Res; 1992 Dec; 52(23):6531-8. PubMed ID: 1330295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
    Murakami A; Tanaka H; Matsuzawa A
    Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.
    Kiyozuka Y; Asai A; Senzaki H; Uemura Y; Nakashima A; Morimoto J; Matsuzawa A; Tsubura A
    Int J Mol Med; 1998 Oct; 2(4):437-44. PubMed ID: 9857231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in metallothionein expression in transplantable mouse mammary tumor lines.
    Yamamura Y; Sayama K; Takeda Y; Matsuzawa A; Iguchi T; Ohta Y
    Cancer Lett; 1999 Apr; 138(1-2):167-74. PubMed ID: 10378789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours.
    Oikawa T; Matsuzawa A; Iwaguchi T
    Br J Cancer; 1986 Jul; 54(1):91-6. PubMed ID: 2425838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors.
    Matsuzawa A; Hayakawa T; Takitani S; Iwaguchi T
    Endocrinology; 1987 Jun; 120(6):2346-56. PubMed ID: 3569134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
    Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
    Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
    Matsuzawa A; Kaneko T; Ikeda Y
    Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an antibiotic protease inhibitor, actinonin on the growth within collagen gels of non-metastatic and metastatic mouse mammary tumors of the same origin.
    Sayama K; Goto Y; Iguchi T; Takeda Y; Matsuzawa A
    Cancer Lett; 1995 Aug; 94(2):171-7. PubMed ID: 7634245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-binding patterns in transplantable mouse mammary tumors and their metastases.
    Tsubura A; Morii S; Matsuzawa A
    Anticancer Res; 1991; 11(5):1719-23. PubMed ID: 1768042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of tumorigenic potential in virgin mice of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by enzymatic cell dissociation.
    Matsuzawa A; Kaneko T; Murakami A; Tanaka H
    Carcinogenesis; 1988 Jun; 9(6):971-7. PubMed ID: 2836107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
    Matsuzawa A; Ikeda Y
    Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog.
    Matsuzawa A; Yamamoto T
    Eur J Cancer Clin Oncol; 1982 May; 18(5):495-505. PubMed ID: 6811279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
    Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G
    Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein expression in transplantable mouse mammary tumors.
    Yamamura Y; Sayama K; Takeda Y; Matsuzawa A; Iguchi T; Ohta Y
    Anticancer Res; 2000; 20(1A):379-84. PubMed ID: 10769683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Mizuno Y; Yamamoto T
    Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Yamamoto T
    Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormones and epidermal growth factor on the growth of the hormone-responsive 13762NF rat mammary tumor in collagen gel culture.
    Richards JE; Edery M; Osborn RC; Larson LN; Nandi S
    J Natl Cancer Inst; 1986 Apr; 76(4):669-82. PubMed ID: 3007845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.